Stop Bang Score Calculator
Screen for obstructive sleep apnea risk using the STOP-BANG questionnaire. Enter values for instant results with step-by-step formulas.
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist
Medical disclaimer: This calculator is provided for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Results are general estimates and may not reflect your individual circumstances. Always consult a qualified healthcare professional before making decisions about your health.
Formula
STOP-BANG Score = S + T + O + P + B + A + N + G (each 0 or 1, total 0-8)
Eight yes/no questions scored 0-1 each. STOP = Snoring, Tiredness, Observed apnea, blood Pressure. BANG = BMI>35, Age>50, Neck>40cm, Gender (male). Score 0-2 = Low risk, 3-4 = Intermediate risk, 5-8 = High risk for OSA.
Worked Examples
Example 1: Preoperative Patient with High Risk
Problem:A 55-year-old male patient scheduled for knee surgery reports loud snoring, daytime tiredness, and his wife has observed him stop breathing during sleep. He has treated hypertension, BMI of 38, and neck circumference of 43 cm.
Solution:STOP-BANG Score: S (Snoring) = Yes (1) T (Tired) = Yes (1) O (Observed) = Yes (1) P (Pressure) = Yes (1) B (BMI > 35) = Yes (1) A (Age > 50) = Yes (1) N (Neck > 40cm) = Yes (1) G (Male) = Yes (1) Total = 8/8
Result:STOP-BANG Score: 8/8 (High Risk) - Very high probability of severe OSA. Polysomnography and anesthesiology consultation essential before surgery.
Example 2: Low Risk Screening Patient
Problem:A 35-year-old female patient presents for routine health screening. She does not snore, has no daytime sleepiness, no observed apneas, normal blood pressure, BMI of 24, and neck circumference of 34 cm.
Solution:STOP-BANG Score: S (Snoring) = No (0) T (Tired) = No (0) O (Observed) = No (0) P (Pressure) = No (0) B (BMI > 35) = No (0) A (Age > 50) = No (0) N (Neck > 40cm) = No (0) G (Male) = No (0) Total = 0/8
Result:STOP-BANG Score: 0/8 (Low Risk) - Very low probability of OSA. No sleep study indicated at this time.
Frequently Asked Questions
What is the STOP-BANG questionnaire and what does it screen for?
The STOP-BANG questionnaire is an eight-item screening tool designed to identify patients at risk for obstructive sleep apnea (OSA). Developed by Dr. Frances Chung and colleagues at the University of Toronto in 2008, it was originally created for preoperative screening but has since been widely adopted in primary care and other clinical settings. The acronym represents eight risk factors: Snoring, Tiredness, Observed apnea, blood Pressure, BMI, Age, Neck circumference, and Gender. Each item is scored as yes (1 point) or no (0 points), yielding a total score of 0 to 8. The questionnaire takes less than two minutes to complete and requires no special equipment or training.
How are STOP-BANG scores interpreted for OSA risk stratification?
STOP-BANG scores categorize patients into three risk groups for obstructive sleep apnea. A score of 0 to 2 indicates low risk, with a high negative predictive value of approximately 90 percent for moderate-to-severe OSA. A score of 3 to 4 indicates intermediate risk, where further clinical evaluation and possible sleep testing may be warranted. A score of 5 to 8 indicates high risk, with strong predictive value for moderate-to-severe OSA. Studies have shown that higher scores correlate with greater OSA severity, with scores of 7 to 8 having very high probability of severe OSA (AHI greater than 30). The simple scoring makes it practical for rapid clinical decision-making in various healthcare settings.
Why is BMI greater than 35 specifically chosen as the cutoff in STOP-BANG?
A BMI greater than 35 kg/m2 was selected as the STOP-BANG threshold because it represents Class II obesity, which is associated with substantially increased risk of obstructive sleep apnea. Excess adipose tissue in the upper airway region, including the tongue, soft palate, and lateral pharyngeal walls, narrows the airway and increases collapsibility during sleep. Studies have demonstrated that the prevalence of OSA increases progressively with BMI, with approximately 70 to 80 percent of morbidly obese patients having some degree of OSA. The relationship between obesity and OSA is bidirectional, as untreated OSA can promote weight gain through metabolic dysregulation, sleep fragmentation, and decreased physical activity. Weight loss of 10 to 15 percent can significantly reduce OSA severity.
What is the significance of neck circumference in predicting sleep apnea?
Neck circumference greater than 40 centimeters (approximately 15.7 inches) is a significant predictor of obstructive sleep apnea because it reflects increased soft tissue volume around the upper airway. A larger neck circumference indicates greater fat deposition in the pharyngeal region, which narrows the airway lumen and increases its vulnerability to collapse during sleep when muscle tone decreases. Research has consistently shown that neck circumference is one of the strongest anthropometric predictors of OSA, sometimes outperforming BMI in predictive accuracy. Neck circumference is also easier to measure accurately than BMI in clinical settings and can identify patients at risk who may not be classified as obese by standard BMI criteria, particularly muscular individuals.
How does the STOP-BANG compare to other sleep apnea screening tools?
The STOP-BANG questionnaire has been compared extensively to other OSA screening tools including the Berlin Questionnaire, Epworth Sleepiness Scale, and the STOP questionnaire (the first four items only). Multiple systematic reviews have found that the STOP-BANG has the highest sensitivity among available screening tools, ranging from 83 to 100 percent for moderate-to-severe OSA at the cutoff of 3 or higher. However, its specificity is relatively lower, ranging from 37 to 56 percent, meaning it produces more false positives than some alternatives. The Berlin Questionnaire may have higher specificity but lower sensitivity and takes longer to administer. The STOP-BANG strikes the best balance between simplicity, speed, and sensitivity for a screening tool in clinical practice.
Why is the STOP-BANG particularly important for preoperative screening?
Preoperative screening for OSA using the STOP-BANG is critical because undiagnosed OSA significantly increases perioperative risk. Patients with untreated OSA are at higher risk for difficult intubation, postoperative respiratory complications, cardiac arrhythmias, and intensive care unit admission. General anesthesia and opioid analgesics further compromise upper airway patency in OSA patients, increasing the risk of postoperative airway obstruction and oxygen desaturation. The American Society of Anesthesiologists guidelines recommend screening surgical patients for OSA, and the STOP-BANG is specifically endorsed for this purpose. Identifying high-risk patients preoperatively allows anesthesiologists to plan appropriate airway management, monitoring, and postoperative care strategies.
What is the difference between the STOP portion and the BANG portion of the questionnaire?
The STOP and BANG portions capture different types of risk information for obstructive sleep apnea. The STOP portion (Snoring, Tiredness, Observed apnea, blood Pressure) consists of symptom-based and clinical history questions that reflect current manifestations of possible OSA. These are subjective or clinically identified signs that suggest the presence of sleep-disordered breathing. The BANG portion (BMI, Age, Neck circumference, Gender) consists of demographic and anthropometric risk factors that are objective and easily measured. When used alone, the STOP questions have moderate sensitivity and specificity. Adding the BANG criteria significantly improves the sensitivity of the tool, particularly for detecting moderate-to-severe OSA, at the cost of somewhat reduced specificity.
Can women have obstructive sleep apnea even though male gender is a risk factor?
Absolutely. While male gender is an independent risk factor for OSA, with men having approximately two to three times higher prevalence than premenopausal women, OSA is significantly underdiagnosed in women. The gender disparity narrows considerably after menopause, when hormonal changes reduce the protective effects of progesterone and estrogen on upper airway muscle tone. Women with OSA often present with different or atypical symptoms compared to men, including insomnia, morning headaches, mood disturbances, and fatigue rather than classic loud snoring and witnessed apneas. This atypical presentation contributes to diagnostic delays. Clinicians should maintain a low threshold for evaluating women with sleep complaints, particularly those who are postmenopausal, obese, or have cardiovascular risk factors.
What follow-up testing is recommended after a positive STOP-BANG screen?
After a positive STOP-BANG screen, the gold standard diagnostic test is in-laboratory polysomnography (PSG), which monitors multiple physiological parameters during sleep including brain waves, eye movements, muscle tone, airflow, respiratory effort, oxygen saturation, and heart rhythm. For patients with a high pretest probability of moderate-to-severe OSA (STOP-BANG score of 5 or higher) and no significant comorbidities, home sleep apnea testing (HSAT) with a portable monitoring device may be an acceptable alternative. HSAT is more convenient and less expensive but may underestimate OSA severity and cannot diagnose other sleep disorders. Patients with high STOP-BANG scores and negative HSAT results should undergo in-laboratory PSG for definitive evaluation.
How does untreated obstructive sleep apnea affect overall health outcomes?
Untreated obstructive sleep apnea is associated with significant morbidity and mortality across multiple organ systems. Cardiovascular consequences include hypertension (present in approximately 50 percent of OSA patients), atrial fibrillation, heart failure, coronary artery disease, and stroke. Metabolic effects include insulin resistance, type 2 diabetes, and metabolic syndrome. Neurocognitive impacts include excessive daytime sleepiness, impaired concentration, memory deficits, and increased risk of motor vehicle accidents (two to seven times higher than the general population). OSA is also associated with depression, decreased quality of life, and increased healthcare utilization. Treatment with continuous positive airway pressure (CPAP) has been shown to reduce cardiovascular risk, improve daytime function, and decrease accident risk.
References
- Chung F, et al. STOP Questionnaire: A Tool to Screen Patients for Obstructive Sleep Apnea. Anesthesiology. 2008;108(5):812-821
- Chung F, et al. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. Br J Anaesth. 2012;108(5):768-775
- American Academy of Sleep Medicine - Clinical Practice Guidelines
Background & Theory
History
Reviewed for accuracy by Rahul Singh, Health & Wellness Specialist ยท Editorial policy
Related Calculators
๐งฎChads2 Score Calculator
Calculate the CHADS2 stroke risk score for patients with non-valvular atrial fibrillation.
๐งฎCha2ds2-Vasc Score Calculator
Calculate CHA2DS2-VASc score for stroke risk stratification in atrial fibrillation patients.
๐งฎHas-Bled Score Calculator
Assess bleeding risk in patients on anticoagulation using the HAS-BLED scoring system.
๐งฎHEART Score Calculator for Chest Pain Risk
Risk-stratify emergency department patients with chest pain using the HEART score.
๐งฎTIMI Risk Score Calculator
Calculate the TIMI risk score for STEMI and UA/NSTEMI patients.
๐งฎWells Score Dvt Calculator
Estimate pre-test probability of deep vein thrombosis using the Wells clinical criteria.
๐งฎWells Score PE Calculator
Estimate pre-test probability of pulmonary embolism using the Wells criteria.
๐งฎFramingham Risk Score Calculator
Calculate 10-year cardiovascular disease risk using the Framingham risk assessment model.